Oncology & Cancer

Why cancer immunotherapies don't work for everyone

A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders.

Diseases, Conditions, Syndromes

Immunocompromised population shown to react well to COVID-19 vaccine

First-year Hackensack Meridian School of Medicine (HMSOM) student Elizabeth Titova leveraged her background in phlebotomy and scientific research to publish a new clinical study around COVID-19 vaccination in Microbiology ...

page 6 from 40